The store will not work correctly when cookies are disabled.
1-Amino-5-bromobenzo[h]isoquinoline-8-carboxamide
ID: ALA4876205
PubChem CID: 137464118
Max Phase: Preclinical
Molecular Formula: C14H10BrN3O
Molecular Weight: 316.16
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccc2c(c1)cc(Br)c1ccnc(N)c12
Standard InChI: InChI=1S/C14H10BrN3O/c15-11-6-8-5-7(14(17)19)1-2-9(8)12-10(11)3-4-18-13(12)16/h1-6H,(H2,16,18)(H2,17,19)
Standard InChI Key: OHHWUWXPWKJQHC-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
21.2621 -26.7939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2609 -27.6176 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9731 -28.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9713 -26.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6841 -26.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6848 -27.6135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1010 -26.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3878 -26.3760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1057 -27.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3942 -28.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3941 -28.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1047 -29.2476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8170 -28.8314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8136 -28.0143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5304 -29.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5335 -30.0627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2406 -28.8260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3824 -25.5588 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
21.9750 -28.8437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 10 1 0
9 7 1 0
7 8 2 0
8 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 9 2 0
13 15 1 0
15 16 2 0
15 17 1 0
8 18 1 0
3 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.16 | Molecular Weight (Monoisotopic): 315.0007 | AlogP: 2.83 | #Rotatable Bonds: 1 |
Polar Surface Area: 82.00 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.26 | CX LogP: 2.12 | CX LogD: 2.12 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.68 | Np Likeness Score: -0.33 |
References
1. (2020) Anti-cancer/anti-fibrosis compounds, |